Full Conference Recap: South Beach Symposium 2026

To stay informed with the latest conference insights, follow us on social media and subscribe to receive our eNewsletters.

Familiar Faces at South Beach Symposium 2026

As SBS kicks off in South Beach Miami, scroll through faces familiar to Dermatology Times presenting at the symposium.

Kicking Off MOPD 2026 With Lawrence Schachner, MD

MOPD 2026, SBS’ sister conference, brings together leading experts to review recent therapeutic advances and practical management strategies in pediatric dermatology.

South Beach Symposium 2026: Gold's Top Pearls

Michael Gold, MD, shares insights on safer device use, peptides, GLP-1s, acne, hair therapies, and more.

MOPD 2026 Rookie of the Year: Integrating Endocrine Insight Into Adolescent Acne Care

At MOPD 2026, Kristina Derrick, MD, ScM, links teen acne to hormones and metabolism, highlighting PCOS clues and antiandrogen therapies.

The Intersection of Acne, Atopic Dermatitis, and Modern Skin Care

At MOPD 2026, Nanette Silverberg, MD, and Lisa Swanson, MD, unpack teen AD, fragrance allergy, and social media skin care hype harming barriers.

Depth, Speed, and Durability: What Matters Most in Modern Clinical Trials

David Cotter, MD, PhD, underscored the importance of incorporating quality-of-life and mental health measures into psoriasis clinical trials.

The Digital Dermatologist: Where Visibility Meets Responsibility

At SBS 2026, Karan Lal, MD, and Mohammad Goldust, MD, reveal how social media and AI reshape dermatology trust and care.

Doris Day, MD, on Redefining Anti-Aging in Dermatology

Doris Day, MD, reframes anti-aging: support fibroblasts, longevity pathways, lifestyle and smart fillers for healthier skin quality.

Balancing Molecular Tools With Clinical Judgment

Antonio Torrelo, MD, emphasizes that genetic testing enhances—but never replaces—clinical judgment in pediatric dermatology.

Ablon's Alopecia and Aesthetic Best Practices

Glynis Ablon, MD, FAAD, shares insights on diagnosing alopecia fast, managing aesthetic complications, and choosing evidence-based supplements.

Chronic SD Requires Mechanism-Based Management

At South Beach Symposium 2026, Benjamin Ungar, MD, discussed safer, long-term approaches for seborrheic dermatitis.

Less Is More: A Practical Approach to Tween Skin Care

At MOPD 2026, Lisa Swanson, MD, urges fungal cultures amid terbinafine resistance and warns attendees about risky kids’ skin care trends.

Rethinking Menopause-Related Skin Changes in Clinical Practice

Glynis Ablon, MD, FAAD, examines the intersection of menopause, hormones, and dermatologic health.

Mona Shahriari, MD, FAAD, on OX40-Targeted Therapy in AD

At South Beach Symposium 2026, Mona Shahriari explores OX40/OX40L therapies for atopic dermatitis.

GLP-1s and Skin Health: Clinical Pearls From Gold and Lal

GLP-1 therapies represent a paradigm shift requiring dermatology to integrate metabolic, medical, and aesthetic care.

When Innovation Meets Insurance Barriers With Lisa Swanson, MD

Clinicians are increasingly facing barriers when attempting to prescribe on-label treatments for indicated patients.

Raising the Bar for HS Outcomes With Barry Resnik, MD

Modern hidradenitis suppurativa (HS) management prioritizes restoration of function and quality of life, not just reduction in lesion counts, according to Barry Resnik, MD.

Christopher Bunick, MD, PhD, on Expanding Targets in Inflammatory Skin Disease

Bispecific and trispecific biologics are being developed to achieve deeper clearance and more meaningful symptom relief.

How Dermatology Is Leading the Regenerative Movement

Advances in stem cells, exosomes, biomaterials, and RNA technologies are expanding therapeutic options beyond traditional wound-based remodeling.

South Beach Symposium 2026 Showcases Advances in Medical and Aesthetic Dermatology

The 2026 meeting emphasized integrating cutting-edge medical therapies with aesthetic strategies to address both disease control and quality of life.

Transparency and Trust in Off-Label Prescribing

Highlighting conditions like lichen planus, which has no FDA-approved treatments, Lio underscores why clinicians must be comfortable prescribing beyond the label.

Expectation Versus Reality in Chronic Wound Care

Ayman Grada, MD, highlighted the gap between dermatology’s expertise in skin biology and its limited involvement in chronic wound care delivery.

Getting Melanoma Right From the First Biopsy

At the 2026 South Beach Symposium, Joel Claveau, MD, emphasized that accurate early diagnosis and proper staging are the cornerstones of effective melanoma management.

For more insights from SBS and beyond, check out our conference coverage page.